ThermoGenesis Holdings, Inc. (THMO)
OTCMKTS: THMO · Delayed Price · USD
0.140
-0.010 (-6.60%)
Jul 19, 2024, 4:00 PM EDT - Market open
ThermoGenesis Holdings Market Cap
ThermoGenesis Holdings has a market cap or net worth of $2.22 million as of July 22, 2024. Its market cap has decreased by -7.49% in one year.
Market Cap
2.22M
Enterprise Value
8.61M
1-Year Change
-7.49%
Ranking
n/a
Category
Stock Price
$0.14
Market Cap Chart
Since December 1, 1998, ThermoGenesis Holdings's market cap has decreased from $40.20M to $2.22M, a decrease of -94.48%. That is a compound annual growth rate of -10.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 14, 2024 | 2.50M | 31.58% |
Dec 29, 2023 | 1.90M | -42.42% |
Dec 30, 2022 | 3.30M | -72.50% |
Dec 31, 2021 | 12.00M | -26.38% |
Dec 31, 2020 | 16.30M | 30.40% |
Dec 31, 2019 | 12.50M | 115.52% |
Dec 31, 2018 | 5.80M | -80.60% |
Dec 29, 2017 | 29.90M | -11.54% |
Dec 30, 2016 | 33.80M | 356.76% |
Dec 31, 2015 | 7.40M | -82.00% |
Dec 31, 2014 | 41.10M | 141.76% |
Dec 31, 2013 | 17.00M | 22.30% |
Dec 31, 2012 | 13.90M | 19.83% |
Dec 30, 2011 | 11.60M | -76.52% |
Dec 31, 2010 | 49.40M | 52.47% |
Dec 31, 2009 | 32.40M | 34.44% |
Dec 31, 2008 | 24.10M | -72.61% |
Dec 31, 2007 | 88.00M | -62.84% |
Dec 29, 2006 | 236.80M | 6.71% |
Dec 30, 2005 | 221.90M | -22.22% |
Dec 31, 2004 | 285.30M | 39.24% |
Dec 31, 2003 | 204.90M | 183.40% |
Dec 31, 2002 | 72.30M | -5.74% |
Dec 31, 2001 | 76.70M | 65.30% |
Dec 29, 2000 | 46.40M | -6.26% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 814.94B |
Novo Nordisk | 579.91B |
UnitedHealth Group | 520.32B |
Johnson & Johnson | 372.29B |
Merck & Co. | 318.55B |
AbbVie | 304.29B |
AstraZeneca | 244.04B |
Novartis AG | 207.64B |